Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term effects of somatostatin analogues in rat GH-secreting pituitary tumor cell lines.

Journal of endocrinological investigation·2021
Same author

Fully automated counting of DNA damage foci in tumor cell culture: A matter of cell separation.

DNA repair·2021
Same author

Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6<sup>+</sup>B helper T cells in systemic lupus erythematosus.

Proceedings of the National Academy of Sciences of the United States of America·2020
Same author

Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis.

Lupus·2020
Same author

An automatable platform for genotoxicity testing of nanomaterials based on the fluorometric γ-H2AX assay reveals no genotoxicity of properly surface-shielded cadmium-based quantum dots.

Nanoscale·2019
Same author

Unmet Needs in the Treatment of RA in the Era of Jak-i: IDRA (Italian Delphi Rheumatoid Arthritis) Consensus.

BioMed research international·2018

Related Experiment Video

Updated: Apr 23, 2026

Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS
12:19

Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS

Published on: October 7, 2009

29.5K

Autoantibody profiling in APS.

D Roggenbuck1, V Somma2, P Schierack3

  • 1Research and Development Department, Medipan GmbH, Dahlewitz/Berlin, Germany Faculty of Science, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany dirk.roggenbuck@hs-lausitz.de.

Lupus
|September 18, 2014
PubMed
Summary
This summary is machine-generated.

Detecting antiphospholipid antibodies (aPL) is crucial for diagnosing antiphospholipid syndrome (APS). A novel multiplex line immunoassay (LIA) offers a promising solution for aPL profiling, addressing current laboratory challenges.

Keywords:
Antiphospholipid syndromeantiphospholipid antibodyline immunoassay

More Related Videos

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

38.6K
Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

12.4K

Related Experiment Videos

Last Updated: Apr 23, 2026

Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS
12:19

Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS

Published on: October 7, 2009

29.5K
Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

38.6K
Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

12.4K

Area of Science:

  • Immunology
  • Clinical Chemistry
  • Rheumatology

Background:

  • Antiphospholipid syndrome (APS) diagnosis relies equally on clinical and laboratory criteria.
  • Antiphospholipid antibodies (aPL) are key diagnostic markers, but their detection is challenging due to heterogeneity.
  • The role of aPL targeting various phospholipids beyond cardiolipin requires further investigation.

Purpose of the Study:

  • To evaluate a novel multiplex line immunoassay (LIA) for antiphospholipid antibody (aPL) profiling.
  • To assess the utility of a new assay technique for simultaneous detection of diverse aPL.
  • To address the laboratory challenges in aPL detection for APS diagnosis.

Main Methods:

  • Evaluation of a novel multiplex LIA utilizing a hydrophobic membrane.
  • Coating of the membrane with various phospholipid-binding proteins and phospholipids.
  • Simultaneous detection of multiple aPL using the developed assay.

Main Results:

  • The novel multiplex LIA demonstrated effective performance characteristics.
  • The assay proved useful for comprehensive aPL profiling.
  • This technique offers a potential advancement over traditional methods like ELISA.

Conclusions:

  • Multiplex LIA is a valuable tool for aPL profiling in APS diagnostics.
  • This assay addresses the heterogeneity challenge in aPL detection.
  • Further research may integrate this technique into routine APS classification.